ConductScience.org, home

Paper23136552

IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.

Rose-John S. Int J Biol Sci, 2012. Cited by 855 papers, by iCite.

Cite this record

ConductScience Library. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Papers, record 23136552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23136552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.
PubMed
Journal
Int J Biol Sci
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
855
iCite
Relative citation ratio, by iCite
24.7
iCite
Revised in PubMed
2022-04-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rose-John SStefan

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytokine Receptor gp130Major topic
Interleukin-6Major topic
Models, BiologicalMajor topic
Receptors, Interleukin-6Major topic
Animals
Humans
Mice
Mice, Transgenic
Signal Transduction
Solubility

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02963480Investigation of Inflammatory Parameters in a Perioperative Closed-meshed Standard Progress in CPB PatientsBackground

Source ClinicalTrials.gov

Download CSV of trials

References104

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112960349Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130.J Immunol2003https://conductscience.org/library/papers/12960349PubMed
216648838Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.Nature2006https://conductscience.org/library/papers/16648838PubMed
321881215Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.J Clin Invest2011https://conductscience.org/library/papers/21881215PubMed
417496315Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.Int Immunol2007https://conductscience.org/library/papers/17496315PubMed
512633863The human interleukin-6 (IL-6) receptor exists as a preformed dimer in the plasma membrane.FEBS Lett2003https://conductscience.org/library/papers/12633863PubMed
619109195Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis.J Immunol2009https://conductscience.org/library/papers/19109195PubMed
78436181The soluble interleukin-6 receptor is generated by shedding.Eur J Immunol1993https://conductscience.org/library/papers/8436181PubMed
811121117Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.Eur J Biochem2001https://conductscience.org/library/papers/11121117PubMed
916707558Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.J Leukoc Biol2006https://conductscience.org/library/papers/16707558PubMed
102783334The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.J Exp Med1989https://conductscience.org/library/papers/2783334PubMed
1121296109The pro- and anti-inflammatory properties of the cytokine interleukin-6.Biochim Biophys Acta2011https://conductscience.org/library/papers/21296109PubMed
128751912Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor.Infect Immun1996https://conductscience.org/library/papers/8751912PubMed
1316912301Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display.J Virol2006https://conductscience.org/library/papers/16912301PubMed
1415485627TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.Immunity2004https://conductscience.org/library/papers/15485627PubMed
1516682432STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice.Gut2006https://conductscience.org/library/papers/16682432PubMed
1620083667Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells.J Immunol2010https://conductscience.org/library/papers/20083667PubMed
1718453602IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens.J Immunol2008https://conductscience.org/library/papers/18453602PubMed
188755571Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8755571PubMed
1919185844gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.Cancer Cell2009https://conductscience.org/library/papers/19185844PubMed
208353278Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130.Blood1993https://conductscience.org/library/papers/8353278PubMed

See all 104 referencesDownload CSV of references

Cited by594

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 855 citations.

PMIDTitleJournalYearIn PapersSource
42940047The Mitophagy Vortex: Bridging Inflammatory, Oxidative, Hypoxic, and Aging Insults to Drive COPD Skeletal Muscle Dysfunction.Biomedicines2026https://conductscience.org/library/papers/42940047PubMed
42930548Interleukin-Driven Inflammation and Cardiovascular Risk in People Living with HIV: Mechanisms, Biomarkers, and Emerging Preventive Strategies.Med Sci (Basel)2026https://conductscience.org/library/papers/42930548PubMed
42902348Blocking IL-6 trans-signaling mitigates benzalkonium chloride-induced inflammation, oxidative imbalance, ER stress, and barrier disruption in human corneal epithelial cells.Eye Vis (Lond)2026https://conductscience.org/library/papers/42902348PubMed
42897323Meprin β is specifically inhibited by its cognate synthetic propeptide.Cell Mol Life Sci2026https://conductscience.org/library/papers/42897323PubMed
42892641IL-1β/IL-6 inflammatory crosstalk drives DNA methylation and histone remodeling associated with cytokine induced senescence in luminal breast cancer.Inflamm Res2026https://conductscience.org/library/papers/42892641PubMed
42840991From IL-6 production to IL-6R buffering: a unified IL-6-IL-6R framework for immune homeostasis during viral infection.Front Immunol2026https://conductscience.org/library/papers/42840991PubMed
42805593Lipotoxicity Amplifies IL-6 Trans-Signaling in Sinusoidal Endothelial Cells to Promote Endotheliopathy and Liver Injury.J Gastroenterol Hepatol2026https://conductscience.org/library/papers/42805593PubMed
42769565Failed resolution as a mechanistic basis of difficult-to-treat rheumatoid arthritis: stromal-myeloid crosstalk in the synovium and emerging resolution-restoring therapies.Front Immunol2026https://conductscience.org/library/papers/42769565PubMed
42769245Changes in circulating immune cells and cytokines after high-intensity aerobic exercise in patients with prostate cancer undergoing active surveillance from the ERASE randomized controlled trial.Front Immunol2026https://conductscience.org/library/papers/42769245PubMed
42737564Interleukin-6 as an Oral-Vascular Inflammatory Bridge: Integrating CXCL10 and Haptoglobin 2-2 into a Potential Model of Periodontitis-Associated Cardiovascular Risk.Int J Mol Sci2026https://conductscience.org/library/papers/42737564PubMed
42724928The inflammation-immunosuppression loop as a driver of immune dysfunction and secondary infections in severe COVID-19.Front Immunol2026https://conductscience.org/library/papers/42724928PubMed
42687879Uterine factor infertility-current understanding and limitations.Uterine Res2026https://conductscience.org/library/papers/42687879PubMed
42670519Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis.J Inflamm Res2026https://conductscience.org/library/papers/42670519PubMed
42662469A proposed convergent molecular chain linking senescence, cancer, and chronic infection to a correctable failure of dendritic cell instruction.Front Immunol2026https://conductscience.org/library/papers/42662469PubMed
42639359Interleukin-6 in complications of prematurity: from biomarker to targeted therapy.Front Pediatr2026https://conductscience.org/library/papers/42639359PubMed
42631138Effect of adding biologic agents to disease-modifying anti-rheumatic drugs for refractory chronic suppurative otitis media: comparative outcomes and cytokine-driven mechanisms.Am J Transl Res2026https://conductscience.org/library/papers/42631138PubMed
42627929NF1 Leucine Rich Domain-Derived Extracellular Vesicles Remodel the Glioblastoma Immune Microenvironment via an ADAM17-Associated Inflammatory Program.J Extracell Vesicles2026https://conductscience.org/library/papers/42627929PubMed
42619373Exerkines in precision management of metabolic diseases.Chin Med J (Engl)2026https://conductscience.org/library/papers/42619373PubMed
42613859Hypothalamus-Peripheral Organ Crosstalk in Energy Metabolism: A Bidirectional Regulatory Network.Endocrinol Metab (Seoul)2026https://conductscience.org/library/papers/42613859PubMed
42579216Quantum and nanoscale sensing of microinflammation for earlier detection of chronic inflammatory and neuroimmune disease.Discov Nano2026https://conductscience.org/library/papers/42579216PubMed

See all 594 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23136552

GET https://conductscience.org/api/papers/v1/23136552/references?page=2